54 157 (Montelukast sodium 10 mg (base))

Pill imprint 54 157 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of asthma, maintenance; asthma; hay fever; bronchospasm prophylaxis; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Images for 54 157 (Montelukast sodium 10 mg (base))

Montelukast sodium 10 mg (base) 54 157
Montelukast sodium 10 mg (base) 54 157
Montelukast sodium
54 157
10 mg (base)
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Roxane Laboratories, Inc.
National Drug Code (NDC):
Inactive Ingredients:
ferric oxide red
ferric oxide yellow
polyethylene glycol 3350
magnesium stearate
microcrystalline cellulose
polyvinyl alcohol
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Watch this video series to learn about managing severe allergies (anaphylaxis).